Prognostic significance of the expression of Cox-2 in lung cancer

Chinese Journal of Cancer Prevention and Treatment

Volumn 14, Issue 23, 2007, Pages 1789-1791

  Sun, Li Mei ^a   Wang, Lu Jian ^a   Fan, Jun ^a   Zhao, Hai Hua ^a   He, An Guang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Antigen, CD34; Immunohistochemistry; Lung neoplasms pathology; Prognosis; Prostaglandin endoperoxide synthase

Indexed keywords

CD34 ANTIGEN; CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; CANCER STAGING; CAPILLARY DENSITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TUMOR VASCULARIZATION;

EID: 77953448799     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Riedl K, Krysan K, Pold M, et al. Multifaceted roles of cyclooxygenase-2 in lung cancer[J]. Drug Resist Updat, 2004, 7 (3):169-184.
2. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors [J]. Breast Cancer Res Treat, 1995, 36(2):169-180.
3. Mattia C, Coluzzi F. Cox-2 inhibitors: pharmacological data and adverse effects [J]. Minerva Anestesiol, 2005, 71 (7-8): 461-470.
4. Luan Y, Xu W. The function of the selective inhibitors of cyclooxygenase 2[J]. Mini Rev Med Chem, 2006, 6(12):1375-1381.
5. Cai Q, Gao Y T, Chow W H, et al. Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk[J]. J Clin Oncol, 2006,24(31):5010-5016.
6. Lanza-Jacoby S, Burd R, Rosato F E Jr, et al. Effect of simultaneous inhibition of epidermal growth factor receptor and cyclooxygenase-2 in HER-2/neu-positive breast cancer[J]. Clin Cancer Res,2006,12 (20 Pt 1):6161-6169.
7. Lev-Ari S, Starr A, Vexler A, et al. Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity[J]. Anticancer Res, 2006, 26 (6B):4423-4430.
8. Kim H S, Youm H R, Lee J S, et al. Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer[J]. Lung Cancer, 2003, 42(2):163-170.